Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ILK | Q13418 | 4/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.41 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.41 |
| ▸ | RAD52 | P43351 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21675451 | 1.00 | ILK (0.43) | ILKHDAC1NPC1RAB9ALMNA | |
| SCHEMBL21675553 | 1.00 | ILK (0.43) | ILKHDAC1NPC1RAB9ALMNA | |
| SCHEMBL21413246 | 1.00 | ILK (0.43) | ILKHDAC1NPC1RAB9ALMNA | |
| SCHEMBL21675476 | 0.99 | ILK (0.44) | ILKHDAC1NPC1RAB9ALMNA | |
| SCHEMBL23185864 | 0.94 | NPC1 (0.43) | ILKHDAC1NPC1RAB9ALMNA | |
| SCHEMBL15722746 | 0.88 | NPC1 (0.46) | ILKNPC1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL16705693 | 0.86 | NPC1 (0.50) | HDAC1NPC1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL15722747 | 0.86 | NPC1 (0.50) | HDAC1NPC1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL23185863 | 0.86 | NPC1 (0.50) | HDAC1NPC1RAB9ALMNASMN1; SMN2 | |
| SCHEMBL15722637 | 0.86 | NPC1 (0.50) | HDAC1NPC1RAB9ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114026078-B | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114026078-A | Novel polymerizable liquid crystal | 罗利克技术有限公司 | 2022-02-08 | — | — | CN | disclosed |
| US-10968189-B2 | Method for producing 2-hydrazinobenzothiazole derivative | DIC CORPORATION (JP) | 2021-04-06 | — | — | US | disclosed |
| US-10927087-B2 | Method for producing polymerizable compound | DIC CORPORATION (JP) | 2021-02-23 | — | — | US | disclosed |
| US-10428032-B2 | Polymerizable compound and optically anisotropic body | DIC CORPORATION (JP) | 2019-10-01 | — | — | US | disclosed |
| WO-2019151263-A1 | METHOD FOR PRODUCING 1,1-DISUBSTITUTED HYDRAZINE COMPOUND AND METHOD FOR PRODUCING POLYMERIZABLE COMPOUND | 日本ゼオン株式会社 | 2019-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428032-B2 | Polymerizable compound and optically anisotropic body | CCNY, F12, CCNI | ILK 1743/4885HDAC1 3861/4885NPC1 3592/4885 |
| US-10927087-B2 | Method for producing polymerizable compound | INCENP, INF2, INHA | ILK 732/4885HDAC1 538/4885NPC1 4131/4885 |
| US-10968189-B2 | Method for producing 2-hydrazinobenzothiazole derivative | HAO2, IDH2, HACL2 | ILK 2528/4885HDAC1 625/4885NPC1 2261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.